Powerful beneficial effects of macrophage colony-stimulating factor on -amyloid deposition and cognitive impairment in Alzheimer's disease
Authors:
- Mohammed FilaliMFMohammed Filali
- Martine LessardMLMartine Lessard
- Jane ReltonJRJane Relton
- Gordon WongGWGordon Wong
- Serge RivestSRSerge Rivest
- 21 May 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 132 (4) , 1078-1092
Abstract
Alzheimer's disease is a major cause of dementia in humans. The appearance of cognitive decline is linked to the overproduction of a short peptide called β-amyloid (Aβ) in both soluble and aggregate forms. Here, we show that injecting macrophage colony-stimulating factor (M-CSF) to Swedish β-amyloid precursor protein (APPSwe)/PS1 transgenic mice, a well-documented model for Alzheimer's disease, on a weekly basis prior to the appearance of learning and memory deficits prevented cognitive loss. M-CSF also increased the number of microglia in the parenchyma and decreased the number of Aβ deposits. Senile plaques were smaller and less dense in the brain of M-CSF-treated mice compared to littermate controls treated with vehicle solution. Interestingly, a higher ratio of microglia internalized Aβ in the brain of M-CSF-treated animals and the phagocytosed peptides were located in the late endosomes and lysosomes. Less Aβ40 and Aβ42 monomers were also detected in the extracellular protein enriched fractions of M-CSF-treated transgenic mice when compared with vehicle controls. Finally, treating APPSwe/PS1 mice that were already demonstrating installed Aβ pathology stabilized the cognitive decline. Together these results provide compelling evidence that systemic M-CSF administration is a powerful treatment to stimulate bone marrow-derived microglia, degrade Aβ and prevent or improve the cognitive decline associated with Aβ burden in a mouse model of Alzheimer's disease.Keywords
This publication has 40 references indexed in Scilit:
- Colony-stimulating factors in inflammation and autoimmunityNature Reviews Immunology, 2008
- Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42and Delay the Cognitive Decline in a Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2008
- Activation of Microglia Acidifies Lysosomes and Leads to Degradation of Alzheimer Amyloid FibrilsMolecular Biology of the Cell, 2007
- Assessing nest building in miceNature Protocols, 2006
- RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memoryNature, 2006
- Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's DiseaseNeuron, 2006
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Immunotherapeutic Approaches to Alzheimer's DiseaseScience, 2003
- Microglia and inflammatory mechanisms in the clearance of amyloid β peptideGlia, 2002
- Expression of Macrophage Colony-Stimulating Factor Receptor Is Increased in the AβPPV717F Transgenic Mouse Model of Alzheimer’s DiseaseThe American Journal of Pathology, 2000